Private Eye

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

CEO and CFO buying at Sirona Biochem (V:SBM)

Updated Tuesday Mar 05, 2019 01:53 AM EDT

Howard Jarman Verrico, CEO and Director, acquired 960,000 Common Shares on a direct ownership basis at a price of $0.100 through a prospectus or prospectus exempt offering on February 27th, 2019. The insider also acquired 960,000 Warrants with an exercise price of $0.160 for 3 years. This represents a $96,000 investment into the company's shares and an account share holdings change of 15.4%.

In addition, Christopher Hopton, CFO and Director, acquired 350,000 Common Shares and 350,000 Warrants on a direct ownership basis. This represents a $35,000 investment into the company's shares and an account share holdings change of 46.1%.

Sirona Biochem is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Sirona Biochem Corp. is a Canada-based development-stage cosmetic ingredient and drug discovery company with a technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. It is engaged in the development of cosmetic and pharmaceutical active ingredients, which are licensed to its partners. The Company has six product lines: SGLT2 Inhibitor, Skin Lightener I, GlycoProteMin-Anti aging, Anti-inflammatory, Anti-infective and Skin Lightener II. Its development is focused on three programs: therapeutics, which includes diabetes, anti-inflammatories and anti-infectives; cosmeceuticals, which includes anti-aging and depigmenting agents (skin lighteners), and biological ingredients, which includes inducers and adjuvants for biological development and preservation. The Company, through TFChem S.A.R.L. (TFC), is engaged in using fluorine atom properties to develop glycomimetic compounds.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
Mixed
N/A
N/A
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to Sirona Biochem Corp. (SBM)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $SBM.CA

  • No tweets found

Stocktwits

Sirona Biochem Corp.

  • Symbol not found.